title: Migraine in women.
abstract: Of the nearly 32 million Americans with migraine, 24 million are women. It is a disorder affecting women throughout their lifetimes, from childhood and puberty through the postmenopausal years. In childhood, before puberty girls are afflicted with migraine at approximately the same rate as boys, but after puberty, there is an emerging female predominance. Estrogen plays a key role in this epidemiologic variation but is not the only factor. There are numerous times when hormonal influences have an impact on migraine and its pattern, including menarche, oral contraceptive use, pregnancy, perimenopause, and menopause. Hence practitioners treating women with migraine need to have a clear understanding of these special considerations.
authors.affiliation: Department of Medicine, Division of Neurology, Centre For Headache, Women's College Hospital, 76 Grenville Street, Toronto, Ontario, Canada. christine.lay@wchospital.ca
authors.forename: Christine L
authors.initials: CL
authors.lastname: Lay
authors.forename: Susan W
authors.initials: SW
authors.lastname: Broner
mesh_terms: D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use; D004967:Estrogens / Q000378:metabolism*; D005260:Female; D006801:Humans; D008572:Menarche / Q000378:metabolism*; D008593:Menopause / Q000378:metabolism*; D008598:Menstruation / Q000378:metabolism*; D008881:Migraine Disorders / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology* / Q000523:psychology; D011247:Pregnancy / Q000378:metabolism*; D012307:Risk Factors
chemical_list: D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens